Quick answer: Semax and Selank are both ACTH/peptide-derived nootropic research compounds, but they’re studied for different things. Semax is researched mainly for cognition, focus, and neuroplasticity through BDNF and dopamine modulation. Selank is researched mainly for anti-anxiety (anxiolytic) effects through GABA and enkephalin pathways. Researchers often study them together as a stimulating-plus-calming pair. Sold for research use only.
The core distinction
The simplest framing: Semax is the “focus/neuroplasticity” research peptide; Selank is the “calm/anxiolytic” research peptide. Both raise BDNF in hippocampal tissue, but their primary mechanisms and research applications diverge from there.
Side-by-side
| Semax | Selank | |
|---|---|---|
| Derived from | ACTH(4–10) fragment analogue | Tuftsin analogue |
| Primary studied mechanism | BDNF/NGF + dopamine and serotonin modulation; TrkB activation | Enkephalinase inhibition (extends enkephalin tone); GABAergic + BDNF |
| Main research angle | Cognition, focus, neuroplasticity, neuroprotection | Anxiolytic, mood stabilization, stress response |
| Typical research framing | “Stimulating / pro-cognitive” | “Calming / anti-anxiety” |
Mechanisms in more detail
Semax rapidly increases hippocampal BDNF-mRNA and TrkB phosphorylation in animal models, and modulates dopamine and serotonin — the basis for its use in cognition, attention, and neuroplasticity research, plus neuroprotection models (e.g., ischemia research).
Selank inhibits enkephalinase, extending the half-life of endogenous enkephalins and potentiating opioid tone without directly stimulating opioid receptors, alongside GABAergic signaling and hippocampal BDNF upregulation — the basis for its anxiolytic and mood-research applications.
Why researchers study them together
Anxiety-related stress signaling can suppress BDNF and impair neuroplasticity. Because Selank reduces stress-pathway activation while Semax drives neurotrophic signaling, the pair is studied as a dual-mechanism tool for stress-cognition interaction models — a stimulating + calming combination.
Frequently asked questions
What is the difference between Semax and Selank?
Semax is studied for cognition and neuroplasticity via BDNF and dopamine; Selank is studied for anti-anxiety effects via GABA and enkephalin pathways.
Which is the “focus” peptide and which is the “calm” peptide?
In research framing, Semax is the focus/neuroplasticity compound and Selank is the calming/anxiolytic compound.
Do both increase BDNF?
Yes — both upregulate hippocampal BDNF, but Semax’s primary angle is neurotrophic/dopaminergic while Selank’s is anxiolytic.
Can they be studied together?
Yes — the stimulating-plus-calming pairing is a common dual-mechanism research design.
Are these for human use?
No. Portal to Wellness sells these strictly for laboratory and research use only. Nothing here is medical advice.
Primary-literature anchors
Cite primary sources: Semax BDNF/TrkB and dopamine research (Russian neuropharmacology literature); Selank enkephalinase-inhibition and anxiolytic research. Link via PubMed.
For research use only. Not for human or veterinary use, diagnosis, treatment, or prevention of any condition. Not evaluated by the FDA. Author: Charles Fowler. Last updated: May 2026.